; table of contents. Title I—Growth in Business Investment to Boost American Wages and Jobs Sec. 101. Permanent full expensing for qualified property. Sec. 102. Limitation on business interest permanently applied without regard to deductions for depreciation, amortization, and depletion. Title II—Growth in Research in America Sec. 201. Repeal amortization of research and experimental expenditures. Sec. 202. Doubling the research and experimental tax credit and better access to credits for startups. Sec. 203. Special rules for transfers of intangible property from controlled foreign corporations to United States shareholders. Title III—Growth in America’s Medical Independence Sec. 301. Domestic medical and drug manufacturing credit. Sec. 302. Qualifying advanced medical manufacturing equipment credit. Sec. 303. New medical research expenditure component of credit for increasing research activities. Sec. 304. Refundable portion of research credit for small businesses engaging in specified medical research. Sec. 305. Exception from passive loss rules for investments in specified medical research small business pass-thru entities. Title IV—Growth in Innovation and Technology Breakthroughs Sec. 401. Simplification and expansion of deduction for start-up and organizational expenditures. Sec. 402. Preservation of start-up net operating losses and tax credits after ownership change. I Growth in Business Investment to Boost American Wages and Jobs 101. Permanent full expensing for qualified property (a) In general Paragraph (6) of section 168(k) of the Internal Revenue Code of 1986 is amended to read as follows: (6) Applicable percentage For purposes of this subsection, the term applicable percentage means, in the case of property placed in service (or, in the case of a specified plant described in paragraph (5), a plant which is planted or grafted) after September 27, 2017, 100 percent. . (b) Conforming amendments (1) Section 168(k) of the Internal Revenue Code of 1986 is amended— (A) in paragraph (2)— (i) in